Prolyl 4-hydroxylase (EC 1.14.11.2) is an essential enzyme in the post-translational modification of collagen. Inhibitors of this enzyme are of potential interest for the treatment of diseases involving excessive deposition of collagen. We have found that anthraquinones with at least two hydroxy groups ortho to each other are potent inhibitors of this enzyme. Kinetic studies revealed that 2,7,8-trihydroxyanthraquinone (THA) competitively inhibited the co-substrate, 2-oxoglutarate, but was non-competitive with regard to ascorbate and was tentatively considered to be uncompetitive with regard to protocollagen. The inhibition by THA was greatly enhanced in the absence of added Fe2+ and was partially reversed by the addition of concentrations of Fe2+ in excess of the optimum for the enzymic reaction. Binding studies indicated that THA is an effective chelating agent for Fe2 . Several non-quinoidal compounds bearing the catechol moiety also inhibited the enzyme. The results suggest that THA inhibited prolyl 4-hydroxylase by binding to the enzyme at the site for 2-oxoglutarate possibly involving the Fe2+ atom, rather than by complexing with Fe2+ in free solution. The inhibition of prolyl 4-hydroxylase by THA exhibited strong positive co-operativity and may involve three distinct but non-independent binding sites.
INTRODUCTION
A critical step in the post-translational modification of collagen pro-a-chains is the hydroxylation of certain prolyl residues (Prockop et al., 1979a) . Two enzymes are involved, prolyl 3-hydroxylase (EC 1.14.11.7) and prolyl 4-hydroxylase (EC 1.14.11.2). The physiological role of the latter enzyme seems well established, since collagen must have about 90 4-hydroxyproline residues per chain in order to form the characteristic triple helix, which is stable at 37°C (Prockop et al., 1979a) . Prolyl 4-hydroxylase has been purified to homogeneity from several sources and is now well-characterized (Prockop et al., 1979a) . The avian enzyme is a tetramer consisting of two different monomers, with Mr of approx. 64000 and 60000, and requires the co-factors Fe2+ ions, molecular oxygen, 2-oxoglutarate and ascorbate. Kivirikko and his colleagues studied the enzymic mechanism in detail Tuderman et al., 1977) and concluded that it involves the sequential binding of Fe2 , 2-oxoglutarate, 02 and the polypeptide substrate. The Fe2+ atom is apparently in thermodynamic equilibrium with the enzyme and is believed to form part of its active centre (Majamaa et al., 1984) .
The importance of prolyl-4-hydroxylase to the correct processing and subsequent secretion ofcollagen (Prockop et al., 1979a) suggests that it could be a useful target for a new generation of drugs to treat diseases involving excessive deposition of collagen and connective tissue. These include fibrosis of the lungs and liver, arteriosclerosis, scleroderma, keloid disease (Prockop et al., 1979b) , the proliferative pannus of rheumatoid arthritis (Boyd, 1970) and possibly muscular dystrophy (Fujii & Murota, 1983) . Among the known inhibitors of prolyl 4-hydroxylase are x'-bipyridine, which is an effective chelator of Fe2+, a number of pyridine mono-and di-carboxylic acids (Majamaa et al., 1984 (Majamaa et al., , 1985 and an antitumour antibiotic, P-1894B (Ishimaru et al., 1982) , otherwise known as vineomycin Al . Unfortunately none of these compounds seems likely to be useful as an effective antifibrotic agent in vivo. During a search for novel inhibitors of prolyl 4-hydroxylase, we discovered that certain polyhydroxylated anthraquinones inhibit purified preparations of this enzyme from embryonic chicks and neonatal rats and also depress collagen deposition in models of fibrosis in vivo (T. J. Franklin& W. P. Morris, unpublished work). In the present paper we describe the effects of polyhydroxyanthraquinones and related compounds on embryonicchick prolyl 4-hydroxylase purified to homogeneity.
MATERIALS AND METHODS Materials
Prolyl 4-hydroxylase was purified from the legs of 17-day chick embryos by the method of Kedersha & Berg (1981) . When examined by SDS/polyacrylamide-gel electrophoresis, the enzyme preparation consisted solely of two proteins of Mr 60000 and 64000, considered to be the subunits of prolyl 4-hydroxylase.
[3H]Proline-labelled protocollagen was prepared by incubating 17-day embryonic-chick calvaria with aa'-bipyridine and L-[3,4,-3H]proline (Amersham International) by the method of Peterkofsky & DiBlasio (1975) . The specific radioactivity of the purified protocollagen was approx. 100 kBq/ng. 2-Oxoglutarate was purchased from C. F. Boehringer & Soehne G.m.b.H., Mannheim, Germany. Ascorbic acid (sodium salt), DL-dithiothreitol, catalase (twice crystallized from bovine liver), bovine serum albumin (essentially fatty acid-free) and Tris were all purchased from Sigma (London) Chemical Co., Poole, Dorset, U.K. THA (2,7,8-trihydroxyanthraquinone) 
Assay of prolyl 4-hydroxylase
Most assays were carried out by measuring the release of 3H, as 3H20, from [3H]prolyl-protocollagen, which accompanies the hydroxylation of proline at the 4-position. The reaction was carried out in a final volume of 0.5 ml, containing 5-10 ng of prolyl 4-hydroxylase, 40 ,tg of [3H]prolyl-protocollagen, 2-oxoglutarate (100 /M), ascorbate (1 mM), dithiothreitol (100 #M), catalase (0.1 mg/ml), bovine serum albumin (2 mg/ml) and 50 /tM-ferrous ammonium sulphate, all dissolved in 50 mM-Tris/HCl buffer, pH 7.6. The mixture was incubated at 37°C and the reaction stopped after 20 min by adding trichloroacetic acid to a final concentration of 5 % (w/v) together with (NH4)2SO4 (50% satn.) and bovine serum albumin (10 mg). The precipitated protein was removed by centrifugation at I1000 g for 8 min, and a sample (1 ml) of the supernatant was mixed with 10 ml of PCS scintillation fluid (Amersham International) for the determination of released 3H by a liquid-scintillation counter. The release of 3H20 remained linear with time over 20 min. Initial velocities were determined by extrapolation from curves plotted with points at 2.5 min intervals. Inhibitors were usually dissolved in dimethyl sulphoxide and added to the reaction mixture to give a final concentration of solvent of 1% (v/v), which had a negligible effect on enzyme activity. The data points were fitted to the best hyperbolae representing the reaction velocity versus substrate concentration by using a computer program ('Hypfit'). The hyperbolae were then transformed into the Lineweaver-Burk plots given in the Results section.
RESULTS

Inhibition of prolyl 4-hydroxylase by THA, and its reversal by Fe2+
The ability of THA to inhibit purified chick prolyl 4-hydroxylase was discovered during a broad search for inhibitors of this enzyme. Fig. 1 indicates that a concentration of 47 #M inhibited the enzyme by 50% (IC50).
The existence of the catechol and the adjacent OH-CO groupings in THA suggested that the compound might complex with Fe2+. The effect of varying the concentrations of Fe2+ in the reaction mixture was therefore tested.
Although prolyl 4-hydroxylase requires added Fe2+ for optimal activity, it will function in the absence of added Fe2+, presumably because sufficient Fe2+ is retained by the enzyme during purification. Fig. 1 shows that the inhibitory activity of THA was markedly increased when Fe2+ was omitted from the reaction mixture, giving an IC50 of 4.6 #M. Fig. 2 Structural requirements for inhibition of prolyl 4-hydroxylase Table 1 shows that a catechol group was important for inhibition of prolyl 4-hydroxylase. Inhibitory activity fell markedly in the monohydroxy anthraquinone (C). The presence or position of a third hydroxy group, as in THA, had little effect on the inhibitory potency of these compounds (A and B). Because of the redox nature of the catalytic cycle of prolyl 4-hydroxylase we considered the possibility that the quinoidal function of the anthraquinones might be involved in their inhibitory action, although anthraquinone (D) itself was inactive at 481 /SM. The hydroxylated xanthones, E and F, were approximately equally as active as THA. This suggests that the redox nature of the anthraquinones is probably not a requirement for the inhibition of prolyl 4-hydroxylase, although it is possible that the modes of action of the catechol-bearing anthraquinones and xanthones are different. 1,2-Dihydroxynaphthalene (G) was also an effective inhibitor of the enzyme, but we have not yet investigated the nature of its inhibitory action.
We thought it important to establish the potential effects of some representative compounds on the concentration of free Fe2+ in solution, in view of the stimulatory action of this metal ion on the activity of isolated prolyl 4-hydroxylase. Our colleagues Dr. J. L. Longridge and Mr. R. G. Button used a potentiometric method to determine the stability constants for mono-and bi-dentate complexes between Fe2+ and some of the inhibitors. The concentrations of the free ligands, Fe2+ and the complexes in incubation buffer at pH 7.4 were then computed by using the COMICS program of Perrin & Sayce (1967) . Table 1 shows that the monohydroxyanthraquinone, C, which was a poor inhibitor of prolyl 4-hydroxylase, was somewhat more effective in complexing Fe2+ than was THA. In contrast, the hydroxyxanthone, E, and dihydroxynaphthalene, which were effective inhibitors of the enzyme, had minimal effects on the concentration of free Fe2+ at pH 7.4. 
However, the monohydroxyanthraquinone, C, shown in Table 1 is also an effective chelator, but it is virtually inactive as an inhibitor of prolyl 4-hydroxylase, whereas compounds such as 1,2-dihydroxynaphthalene and the xanthone, F, which are less effective in lowering the concentration of free Fe2+, are all good inhibitors of prolyl 4-hydroxylase. It might appear, therefore that the chelating property of THA has little to do with its enzyme-inhibiting activity. However, the interaction of Fe2+ with hydroxyanthraquinones is complex. The metal probably binds to the catechol function in addition to the hydroxy-carbonyl system, although the affinity of the latter function for Fe2+ at pH 7.5 is certainly much higher. These considerations may be important in the light of studies by Majamaa et al. (1984) . They found that a series of pyridinecarboxylic acids, capable of forming weak bidentate or terdentate complexes with Fe2 , are effective inhibitors of chick prolyl 4-hydroxylase by competitive antagonism with 2-oxoglutarate. Majamaa et al. (1984) suggested that 2-oxoglutarate binds to the Fe2+ atom at the active centre of the enzyme and additionally to neighbouring hydrophobic and ionic regions of the enzyme. The pyridinecarboxylic acids are believed to inhibit by competing with 2-oxoglutarate for both the Fe2+ atom and the postulated hydrophobic site (Majamaa et al., 1984) . There is some similarity between the inhibitory actions ofTHA and the pyridinecarboxylic acids. THA is a competitive inhibitor of 2-oxoglutarate, but does not compete with either protocollagen or ascorbate. Since THA also complexes with Fe2+ it is possible that, like the pyridinecarboxylates, THA binds to the enzyme via the active Fe2+ atom and conceivably through additional hydrophobic interactions involvin; the aromatic ring system. The strong positive 'ooperativity of the inhibition by THA indicates that several distinct but non-independent binding sites may be involved. Inhibition by pyridine-2,5-dicarboxylate showed no evidence of co-operativity (Majamaa et al., 1984) .
The inactivity of the monohydroxyanthraquinone, C, against prolyl 4-hydroxylase indicates (a) that THA does not inhibit by depleting the concentration of Fe2+ in the medium, since compound C is also an effective chelating agent and (b) that the hydroxy-carbonyl system is unlikely to be involved with binding to the Fe2+ at the active centre of the enzyme. Although the Fe2+-complexing activity of the catechol function is relatively poor at pH 7.4, it is conceivable that an interaction with enzyme-associated Fe2+ could be stabilized by other interactions with neighbouring groups in the enzyme. The ability of added Fe2+ to antagonize the inhibition by THA is probably attributable to the formation of inactive Fe2+ complexes in solution involving the hydroxy-carbonyl system.
At this stage, therefore, we believe that the inhibitory action of THA and possibly other catechols is probably best explained by a primary interaction of the dihydroxy function with Fe2+ at the 2-oxoglutarate-binding site of prolyl 4-hydroxylase, accompanied by secondary interactions with amino acid residues. However, alternative mechanisms may have a role to play. For example, in their studies on the complex antibiotic P-1984B, which contains a hydroxylated anthraquinone moiety flanked by two bulky oligosaccharide units, Ishimaru et al. (1982) suggested, although without direct evidence, that the inhibition of prolyl 4-hydroxylase by this compound might depend on its ability to scavenge a postulated activated oxygen intermediate in the catalytic reaction. However, the inhibitory mechanism of P-1 894B is probably distinct from that of THA, since the former was non-competitive with respect to the synthetic peptide substrate (Pro-Pro-Gly)5, whereas THA was apparently uncompetitive with respect to protocollagen. The competitive relationship between THA and 2-oxoglutarate is not consistent with an activated oxygen-scavenging role for THA. Ishimaru et al. (1982) did not report on the kinetic relationship between 2-oxoglutarate and P-1 894B. Presumably the quinoidal oxygen system would be important in activated oxygen-scavenging activity. The inhibition of prolyl 4-hydroxylase by the structurally related but non-quinoidal xanthones E and F suggests that the quinoidal redox system is not important, although it is conceivable that the inhibitory mechanisms of the hydroxylated anthraquinones and xanthones are different.
A further complexity of the interaction with THA with prolyl 4-hydroxylase is its strong positively co-operative character. This was indicated by a marked inverse relationship between Ki values and the concentration of THA in the kinetic experiments with 2-oxoglutarate: at 19.5 ,tM-THA the Ki was 34.2 /tM, whereas at 48.9 ,tM-THA the value was 3.7 /zM. At present it seems possible that THA interacts with at least three separate but non-independent sites on prolyl hydroxylase. Further experimental work will be necessary to establish the validity of this suggestion.
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